Thomas Cluzeau (@thomas_cluzeau) 's Twitter Profile
Thomas Cluzeau

@thomas_cluzeau

Professor in Hematology department, CHU of Nice, Côte d’Azur University

ID: 930188594727342085

calendar_today13-11-2017 21:40:17

199 Tweet

543 Followers

120 Following

ALL Hub (@all_hub_) 's Twitter Profile Photo

CONGRESS | POSTER | #EHA2024 | Thomas Cluzeau CHU de Nice reports results from the ATHENA study describing real-world utilization of blinatumomab in adult and pediatric patients with ALL in France. Four key uses of blinatumomab were identified: HSCT preparation, adults (31.3%),

CONGRESS | POSTER | #EHA2024 | <a href="/thomas_cluzeau/">Thomas Cluzeau</a> <a href="/CHUdeNice/">CHU de Nice</a> reports results from the ATHENA study describing real-world utilization of blinatumomab in adult and pediatric patients with ALL in France. Four key uses of blinatumomab were identified: HSCT preparation, adults (31.3%),
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

Want to hear about how to approach patients with TP53-mutated MDS and secondary AML?💭 Watch our discussion from #iwMDS24, in which leading experts @ColemanLindsley, David Sallman, & Thomas Cluzeau share their insights: 👉 ow.ly/FEWX50SHZFb #MDSsm #AMLsm #Leusm #HemOnc

VJHemOnc (@vjhemonc) 's Twitter Profile Photo

A massive thank you to Harry Erba (Duke Cancer), Farhad Ravandi (MD Anderson Cancer Center), and Thomas Cluzeau for sharing their insights into prolonging remission in AML! Check out our most recent session: 👉ow.ly/xXLV50TeABO👈 #AMLsm #Leusm #Leukemia #HemOnc

A massive thank you to Harry Erba (<a href="/DukeCancer/">Duke Cancer</a>), Farhad Ravandi (<a href="/MDAndersonNews/">MD Anderson Cancer Center</a>), and <a href="/thomas_cluzeau/">Thomas Cluzeau</a> for sharing their insights into prolonging remission in AML!

Check out our most recent session: 
👉ow.ly/xXLV50TeABO👈

#AMLsm #Leusm #Leukemia #HemOnc
Grupo Español de Citología Hematológica (@ghematologica) 's Twitter Profile Photo

Máximo interés en el Simposio que aborda de forma profunda aspectos diagnósticos, pronósticos y clínicos de neoplasias hematológicas @sehh_es #Hemato2024: Neoplasias mieloides con mutación de TP53. Moderadores:Dr Raya y Dra Prats Ponentes:Dra Guijarro, Dra Calasanz y Dr Cluzeau.

Máximo interés en el Simposio que aborda de forma profunda aspectos diagnósticos, pronósticos y clínicos de neoplasias hematológicas <a href="/sehh_es/">@sehh_es</a> 
#Hemato2024: Neoplasias mieloides con mutación de TP53.
Moderadores:Dr Raya y Dra Prats
Ponentes:Dra Guijarro, Dra Calasanz y Dr Cluzeau.
Thomas Cluzeau (@thomas_cluzeau) 's Twitter Profile Photo

Great Italian French collaboration: Long-term real world evidence of CPX-351 of high-risk AML patients identified high rate of negative MRD and prolonged OS ashpublications.org/bloodadvances/…

VJHemOnc (@vjhemonc) 's Twitter Profile Photo

In a wonderful joint discussion from #iwAL24, experts Richard Stone, Marina Konopleva, & Thomas Cluzeau speak on novel treatments & combinations in AML, commenting on mechanisms of resistance to venetoclax & approaching R/R disease: 🎥 ow.ly/HzFR50U5ZLk #Leusm #AMLsm #HemOnc

VJHemOnc (@vjhemonc) 's Twitter Profile Photo

Spotlight on: Prolonging #Remission In Patients With #AML 🗞️🩸 ✓ The implications of front-line therapy in AML ✓ The role and utilization of #transplantation in AML ✓ Updates in treatments to prolong #remission Take a look 👉 vjhemonc.com/feature/spotli…

Spotlight on: Prolonging #Remission In Patients With #AML  🗞️🩸

✓ The implications of front-line therapy in AML

✓ The role and utilization of #transplantation in AML

✓ Updates in treatments to prolong #remission

Take a look 👉 vjhemonc.com/feature/spotli…
Thomas Cluzeau (@thomas_cluzeau) 's Twitter Profile Photo

Le service d’#hematologie du CHU de Nice grâce au Dr Loschi: Pionnier de l’utilisation thérapeutique du microbiote. Hacking the Microbiome to Fight Cancer youtu.be/P8pd0TlITpo?si… via YouTube Bloomberg TV

Le service d’#hematologie du <a href="/CHUdeNice/">CHU de Nice</a>  grâce au Dr Loschi: Pionnier de l’utilisation thérapeutique du microbiote. Hacking the Microbiome to Fight Cancer youtu.be/P8pd0TlITpo?si… via <a href="/YouTube/">YouTube</a> <a href="/BloombergTV/">Bloomberg TV</a>
CHU de Nice (@chudenice) 's Twitter Profile Photo

[Recherche] 🔬 🎉Félicitations au Pr Thomas Cluzeau du CHU de Nice pour sa recherche d' #excellence : publié dans la revue : #Blood advances "Long-term real world evidence of CPX-351 of high-risk AML patients identified high rate of negative MRD and prolonged OS"

[Recherche] 🔬

🎉Félicitations au Pr Thomas Cluzeau  du <a href="/CHUdeNice/">CHU de Nice</a> pour sa recherche d' #excellence : publié dans la revue  :  #Blood advances
"Long-term real world evidence of CPX-351 of high-risk AML patients identified high rate of negative MRD and prolonged OS"
Thomas Cluzeau (@thomas_cluzeau) 's Twitter Profile Photo

L’#Hematologie du CHU de Nice bien représenté au congrès #mao à Monaco. Brillantes présentations des Dr Richez #myelome, Dr Chiche #lymphome et Dr Loschi #cart

L’#Hematologie du <a href="/CHUdeNice/">CHU de Nice</a> bien représenté au congrès #mao à Monaco. Brillantes présentations des Dr Richez #myelome, Dr Chiche #lymphome et Dr Loschi #cart
Thomas Cluzeau (@thomas_cluzeau) 's Twitter Profile Photo

#ESH #MPN Vienne. Dr Loschi from the Hematology Department CHU de Nice presented the results and perspectives of Selinexor combos in the first Line treatment of #Myelofibrosis patients

#ESH #MPN Vienne. Dr Loschi from the Hematology Department <a href="/CHUdeNice/">CHU de Nice</a> presented the results and perspectives of Selinexor combos in the first Line treatment of #Myelofibrosis patients
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

It was great speaking with Michael Loschi of CHU de Nice to hear about a session on combination therapy in #myelofibrosis at the recent #ESHCMLMPN2025 meeting. Click here to watch the interview: 👉 ow.ly/kh8j50VkB4k 👈 #MPNsm #HemOnc ESH (Haematology)